It's not clear that typical co-founder vesting schedules are really capable of handling this sort of event: a co-founder develops a major disease that limits their ability to work but does not halt it completely.

In most instances like this the co-founder is likely to continue vesting as normal. Whether all parties are happy with this arrangement or not is likely to vary significantly from case to case.